1. Nat Biotechnol. 2010 Aug;28(8):827-38. doi: 10.1038/nbt.1665. Epub 2010 Jul
30.

The MicroArray Quality Control (MAQC)-II study of common practices for the 
development and validation of microarray-based predictive models.

Shi L(1), Campbell G, Jones WD, Campagne F, Wen Z, Walker SJ, Su Z, Chu TM, 
Goodsaid FM, Pusztai L, Shaughnessy JD Jr, Oberthuer A, Thomas RS, Paules RS, 
Fielden M, Barlogie B, Chen W, Du P, Fischer M, Furlanello C, Gallas BD, Ge X, 
Megherbi DB, Symmans WF, Wang MD, Zhang J, Bitter H, Brors B, Bushel PR, Bylesjo 
M, Chen M, Cheng J, Cheng J, Chou J, Davison TS, Delorenzi M, Deng Y, 
Devanarayan V, Dix DJ, Dopazo J, Dorff KC, Elloumi F, Fan J, Fan S, Fan X, Fang 
H, Gonzaludo N, Hess KR, Hong H, Huan J, Irizarry RA, Judson R, Juraeva D, 
Lababidi S, Lambert CG, Li L, Li Y, Li Z, Lin SM, Liu G, Lobenhofer EK, Luo J, 
Luo W, McCall MN, Nikolsky Y, Pennello GA, Perkins RG, Philip R, Popovici V, 
Price ND, Qian F, Scherer A, Shi T, Shi W, Sung J, Thierry-Mieg D, Thierry-Mieg 
J, Thodima V, Trygg J, Vishnuvajjala L, Wang SJ, Wu J, Wu Y, Xie Q, Yousef WA, 
Zhang L, Zhang X, Zhong S, Zhou Y, Zhu S, Arasappan D, Bao W, Lucas AB, Berthold 
F, Brennan RJ, Buness A, Catalano JG, Chang C, Chen R, Cheng Y, Cui J, Czika W, 
Demichelis F, Deng X, Dosymbekov D, Eils R, Feng Y, Fostel J, Fulmer-Smentek S, 
Fuscoe JC, Gatto L, Ge W, Goldstein DR, Guo L, Halbert DN, Han J, Harris SC, 
Hatzis C, Herman D, Huang J, Jensen RV, Jiang R, Johnson CD, Jurman G, Kahlert 
Y, Khuder SA, Kohl M, Li J, Li L, Li M, Li QZ, Li S, Li Z, Liu J, Liu Y, Liu Z, 
Meng L, Madera M, Martinez-Murillo F, Medina I, Meehan J, Miclaus K, Moffitt RA, 
Montaner D, Mukherjee P, Mulligan GJ, Neville P, Nikolskaya T, Ning B, Page GP, 
Parker J, Parry RM, Peng X, Peterson RL, Phan JH, Quanz B, Ren Y, Riccadonna S, 
Roter AH, Samuelson FW, Schumacher MM, Shambaugh JD, Shi Q, Shippy R, Si S, 
Smalter A, Sotiriou C, Soukup M, Staedtler F, Steiner G, Stokes TH, Sun Q, Tan 
PY, Tang R, Tezak Z, Thorn B, Tsyganova M, Turpaz Y, Vega SC, Visintainer R, von 
Frese J, Wang C, Wang E, Wang J, Wang W, Westermann F, Willey JC, Woods M, Wu S, 
Xiao N, Xu J, Xu L, Yang L, Zeng X, Zhang J, Zhang L, Zhang M, Zhao C, Puri RK, 
Scherf U, Tong W, Wolfinger RD; MAQC Consortium.

Author information:
(1)National Center for Toxicological Research, US Food and Drug Administration, 
Jefferson, Arkansas, USA.

Comment in
    Pharmacogenomics. 2011 Apr;12(4):461-3. doi: 10.2217/pgs.11.26.

Gene expression data from microarrays are being applied to predict preclinical 
and clinical endpoints, but the reliability of these predictions has not been 
established. In the MAQC-II project, 36 independent teams analyzed six 
microarray data sets to generate predictive models for classifying a sample with 
respect to one of 13 endpoints indicative of lung or liver toxicity in rodents, 
or of breast cancer, multiple myeloma or neuroblastoma in humans. In total, 
>30,000 models were built using many combinations of analytical methods. The 
teams generated predictive models without knowing the biological meaning of some 
of the endpoints and, to mimic clinical reality, tested the models on data that 
had not been used for training. We found that model performance depended largely 
on the endpoint and team proficiency and that different approaches generated 
models of similar performance. The conclusions and recommendations from MAQC-II 
should be useful for regulatory agencies, study committees and independent 
investigators that evaluate methods for global gene expression analysis.

DOI: 10.1038/nbt.1665
PMCID: PMC3315840
PMID: 20676074 [Indexed for MEDLINE]

Conflict of interest statement: COMPETING FINANCIAL INTERESTS The authors 
declare competing financial interests: details accompany the full-text HTML 
version of the paper at http://www.nature.com/naturebiotechnology/.